Gut microbiota plays a key role in host physiology and metabolism. Indeed, the relevance of a well-balanced gut microbiota composition to an individual´s health status is essential for the person's well-being. Currently, investigations are focused on analyzing the effects of pre-and probiotics as new therapeutic tools to counteract the disruption of intestinal bacterial balance occurring in several diseases. Polyphenols exert a wide range of beneficial health effects. However, although specific attention has been paid in recent years to the function of this "biological entity" in the metabolism of polyphenols, less is known about the modulatory capacity of these bioactive compounds on gut microbiota composition. This review provides an overview of the latest investigations carried out with pure polyphenols, extracts rich in polyphenols and polyphenol-rich dietary sources (such as cocoa, tea, wine, soy products and fruits), and critically discusses the consequences to gut microbiota composition which are produced.
Introduction
Polyphenols are members of a very large family of plant-derived compounds that show an extensive variety of chemical structures. They are classified as flavonoids and nonflavonoids. Among the flavonoids, various groups can be distinguished: flavonols, flavan-3-ols (monomeric and polymeric structures), flavones, isoflavones, flavanones and anthocyanidins. Among non-flavonoids we find stilbenes, hydrolysable tannins and phenolic acids. 1 The polyphenolic profile of vegetables and fruits very much depends on the type of plants, on the conditions under which these plants are grown, on harvest conditions and how these products are stored.
Polyphenols can have beneficial effects on human health, and thus their study has become an increasingly important area of human nutrition research. A great number of epidemiological studies have shown that the consumption of diets rich in fruits and vegetables is associated with a reduction in the risk of suffering chronic diseases, such as cardiovascular diseases, specific cancers or neurodegenerative diseases. In order to confirm these observations, numerous intervention trials have been conducted in recent years. The beneficial effects of phenolic compounds on different health issues have been reviewed elsewhere. 2 Taking into account current scientific evidences about the beneficial effects induced by polyphenol intake, despite the low bioavailability of these molecules, further studies are required to analyze whether polyphenol metabolites contribute to the effects of their parent compounds. However, the investigations reported concerning this topic are scarce. In this context, the role of gut microbiota, which determines to some extent the polyphenol metabolite profile, is an important issue to be addressed. 3, 4 The action of gut microbes on polyphenols leading to the production of metabolites with diverse physiological relevance has been also analyzed in the recent years. 5 This review aims to highlight the impact of phenolic compounds, either as pure compounds or as food constituents, on gut microbiota composition and intends to offer an update of the recent in vitro and in vivo evidence which demonstrates the interaction existing between gut microbes and polyphenols with health impact.
Gut microbiota and health
The intestine is the largest reservoir of human flora, which achieves concentrations of up to 10 11 or 10 12 cells/g and consists of a complex microbial community residing the gut called microbiota. The human body has about 100 trillion microorganisms in the intestine, which is ten times higher than the total number of human cells in the body.
Only a minority of the species that inhabit the human colon has been identified so far, but modern molecular methods such as broad-range sequencing of 16S ribosomal RNA from amplified bacterial nucleic acids extracted from faeces or biopsies, are being used nowadays to identify and classify intestinal bacteria 6 .
Bacteria make up most of the flora in the colon, where around 300-500 different species live. 6 The most common bacteria are Bacteroides which constitute around 30% of all bacteria in the gut, followed by Clostridium, Prevotella, Eubacterium, Ruminococcus, Fusobacterium, Peptococcus, and Bifidobacterium. Escherichia and Lactobacillus are also present, but at lesser extent. 7 It seems that 99% of the bacteria come from about 30 or 40 species. 7 It has been reported that diet has a major influence on gut microbiota and is able to modify their impact on health, with either beneficial or deleterious consequences. 8 Thus, levels of Prevotella are enriched in children who have had a high-fiber diet 9 , as well as in children and adults whose diet is dominated by plant-derived polysaccharide foods, such as maize and cassava. By contrast, the microbiota of people with a long-term diet rich in animal protein and saturated fat has more Bacteroides. 10 These changes can be explained by fiber content of the diet. The increase in colonic fermentation results in a decrease in the pH, from 6.5 to 5.5, due to the high concentrations of short-chain fatty acids. This decrease in the pH has a profound selective effect upon the colonic microbial community in fermentor simulations supplied with soluble polysaccharides, with a tendency to suppress Bacteroides spp. and to promote butyrate-producing grampositive bacteria. 11 However, long-term periods (8-9 weeks) of dietary patterns are needed to induce changes in the microbiota of individuals. 12 During the metabolism of foods and xenobiotics, the host and its gut microbiota coproduce a large amount of small molecules, many of which play critical roles in shuttling information between host cells and the host's microbial symbionts (cross-talk).
In this context, alterations in the microbiome, dysbiosis, modulate the metabolic phenotype of the host, and greatly influence host biochemistry and susceptibility to diseases. 13 Indeed, it has been proposed that gut microbiota are involved in appetite control, energy balance, obesity, diabetes, immune function, allergies, behavioral perturbations, cardiovascular disease and cancers, such as stomach cancer.
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Polyphenols and gut microbiota interactions
The percentage of polyphenol absorption is very low 14 and as much as 90% of these compounds persist into the colon. There, they are metabolized via esterase, glucosidase, demethylation, dehydroxylation and decarboxylation activities of bacteria, 15 resulting in smaller metabolites such as phenolic acids and short chain-fatty acids, some of which can be absorbed across the intestinal mucosa. Interestingly, the microbial bioconversion capacity of each individual influences the final metabolites produced and impacts on their bioavailability. Indeed, since all individuals have their own unique signature of intestinal microbiota, which can make an analogy with a fingerprint, human intestinal microbiota composition can modulate the polyphenol impact on host health.
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On the other hand, polyphenols and their metabolites can affect the intestinal ecology modulating microbiota. 15 In this sense, several phenolic compounds have been identified as potential antimicrobial agents with bacteriostatic or bactericidal actions.
Furthermore, they could also act as inhibitors of infection-causing bacteria within cells of the intestinal and urinary tracts, suggesting that some phenolic compounds have potential to be applied as antimicrobial agents against human infections.
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Despite these positive effects, it is important not to forget that excessive amounts of polyphenols may also inhibit the growth of colonic beneficial microbiota, which is responsible for bioconversion of polyphenols, and thus indirectly interfere with their own bioavailability. Consequently, dietary supplementation may exert a non-desirable effect on human health instead of supporting it.
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Influence of phenolic compounds in gut microbiota composition
The majority of studies encompassing the influence of phenolic compounds on gut microbes have been focused on their anti-microbial activity. However, the concept of polyphenols as potential prebiotic candidates could be considered as a newly emerging concept.
Interestingly, a number of in vitro and in vivo (in animals and humans) studies showing the influence of dietary polyphenols on gut-inhabiting bacteria have been published in recent years.
Flavonoids

Flavanones and flavonols
The impact of some flavanones (naringenin, naringin, hesperetin, hesperidin) and flavonols (quercetin and rutin), on specific intestinal microbial representatives was screened in vitro by Duda-Chodak. 16 For this purpose, pure cultures of 6 bacteria species (Bacteroides galacturonicus, Lactobacillus sp., Enterococcus caccae, Bifidobacterium catenulatum, Ruminococcus gauvreauii and Escherichia coli) were inoculated with pure polyphenols at final concentrations of 4, 20 and 50 µg/mL in the case of quercetin and at 20, 100 and 250 µg/mL for the rest of the compounds.
Naringenin and quercetin exerted a complete and dose-dependent inhibitory effect on the growth of all analyzed bacterial species, whereas this effect was weaker for hesperetin. A higher inhibitory effect of the aglycones, compared to that of the glycosides (naringin, rutin and hesperidin), was demonstrated. 16 The fact that flavanone glycosides were unable to exert any antimicrobial activity was explained by the dependency of the potential of these compounds on the sugar presence/absence in the moiety.
In another in vitro study conducted by Kawabata et al. 17 Bifidobacterium adolescentis, one of the probiotic species usually identified in the intestine of both children and adults, was co-cultured with different flavonols (galangin, kaempferol, quercetin, myricetin and fisetin) and the growth rate measured. 17 All the flavonoids studied, except galangin, showed little or no anti-bacterial effect. In addition, when these conditioned media were exposed to a nitric oxide (NO) production inhibition assay, the co-culture of B. adolescentis with galangin (54%), quercetin (50%) and fisetin (76%) decreased NO synthesis, suggesting an improvement in flavonol anti-inflammatory capacity by B.
adolescentis.
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Backing up these findings, another study tested pure polyphenols at concentrations ranging from 62. 
Flavanols
In a study that investigated the effect of flavanol monomers, namely (-)-epicatechin and (+)-catechin, on the growth of specific bacterial populations, a marked overgrowth of beneficial bacterial groups was noted when microbiota was exposed to 150 mg/L or 1000 mg/L of (+)-catechin. 19 Both concentrations promoted the growth of Eubacterium rectale-Clostridium coccoides, and the lowest concentration was able to induce that of Lactobacillus spp. and Bifidobacterium spp. Moreover, (+)-catechin inoculation at 150 mg/L induced the growth of Escherichia coli and the 1000 mg/L concentration decreased that of Clostridium histolyticum. A significant increase in the growth of Eubacterium rectale-Clostridium coccoides was also reported with the inoculation of (-)-epicatechin at 150 mg/L concentration. 19 The inhibitory potential of (+)-catechin at concentrations raging 20 to 250 µg/mL, on specific intestinal microbial representatives was reported to be powerless as it was only able to slightly slow down the growth of B.
catenulatum (MIC >250 µg/mL), but promoted the growth of E. caccae.
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Polyphenon G powder, a purified preparation of tea-derived catechins, was also reported to induce a significant increase in lactobacilli and a marked decrease in Enterobacteriaceae in broiler chickens.
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The implication of the principal tea phenolic aglycones, epicatechin, catechin, 
Condensed tannins (proanthocyanidins)
Condensed tannins, which are also called proanthocyanidins, are present in a broad number of higher plant species. Regarding the effect of these compounds on gut microbiota, the effects of diet supplementation with low-tannin (0.7%) and high-tannin (2.0%) diets were assessed in rats by Smith et al. 23 Shifts in bacterial populations of faeces were analyzed by DNA fingerprinting and bacterial cultivation and enumeration.
The authors concluded that the most predominant groups in condensed-tannin supplemented animals were those belonging to Enterobacteriaceae, BacteroidesPrevotella-Porphyromonas and the Bacteroides fragilis group.
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Nonflavonoids
Stilbenes
The antimicrobial effects of resveratrol (3,5,4´-trihydroxy-trans-stilbene) against several pathogenic agents has been reported in vitro. When this compound was administered to a DSS-induced colitis rat model, a significant increase in lactobacilli and bifidobacteria, as well as decrease of enterobacteria, was observed after 20 days.
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Hydrolysable tannins (ellagitannins)
Ellagitannins, a type of hydrolysable tannin, are hydrolized in vivo and releases ellagic acid, whose metabolism by gut microbiota results in urolithin production 25 . proanthocyanidins. The fact that cocoa polyphenols ingestion could affect diseases, such as hypertension, oxidative stress, cancer, atherosclerosis, diabetes, and diverse central nervous system disorders, and the fact that these disorders have also been linked to gut microbiota, has opened a research gate to investigating the effect of cocoa or chocolate intake on gut microbiota. In this regard, the faecal microbiota composition was analyzed after a high and continuous (10% w/w) cocoa intake in female Wistar rats. 29 The authors reported significantly lower levels of Bacteroides, Staphylococcus
and Clostridium genera at the end of the intervention. Moreover, reductions in Clostridium species were found to correlate with weight loss and body mass index (BMI) z-score. and C. ramosum, while encouraging the growth of Bifidobacterium spp. in vitro. 31 In an in vitro study conducted by Kemperman et al., 32 the antimicrobial effect of a black tea extract was analyzed by traditional culturing and qPCR, and its impact on microbial community was also assessed by PCR-DGGE and 16S rDNA measurements. 32 Several animal studies conducted in pigs 33 and in calves 34 concluded that tea polyphenols produced an enhancement in animals' intestinal microbiota. Thus, pigs that received 0.2% of tea polyphenols for 2 weeks showed a significant decrease in total bacteria and bacteroidaceae and a tendency to decrease in C. perfringens. By contrast, a significant increase in Lactobacilli was found 33 . Similarly, two types of GTE were tested in vitro (GTE-1 and GTE-2, polyphenol contents >60% and >80%, respectively) and MICs were determined for diverse pathogenic bacteria. As a result of these in vitro analyses, a stronger inhibitory capacity of GTE-2 was concluded, assuming that the higher amounts of (-)-epigallocatechin gallate, (-)-gallocatechin gallate and (-)-epicatechin gallate might be responsible for the observed reduction in bacterial growth. Furthermore, within the large variability of MICs detected for the tested species, the total counts of Bifidobacterium spp. and Lactobacillus spp. were significantly higher in the test group.
In the same study, the growth rate reduction of C. perfringens was faster in calves supplemented with GTE, supporting the potential of GTE to prevent the growth of pathogenic bacteria and to improve microflora balance. 34 In humans, a product containing 70% of tea polyphenols (Sunphenon ® , which included
gallate, (-)-gallocatechin gallate, and (-)-epigallocatechin gallate) was administered (0.4g/volunteer) 3 times per day, for 4 weeks, which was equivalent to 10 cups of concentrated green tea. Results indicated that C. perfringens and other Clostridium spp.
were significantly reduced during the tea polyphenol intake periods, whereas percentages of Bifidobacterium spp. in total faecal counts markedly increased. 35 More recently, bifidobacteria showed a trend to increase in 10 volunteers who drank green tea for 10 days. 36 In a different study, the effect of 4% green tea powder (GT) supplement with or without the addition of Lactobacillus plantarun DSM 15313 (Lp), was evaluated on microbiota of small intestine and caecum of high-fat fed mice. This study showed a synergestic effect with significant increases in Lactobacillus group and bacterial diversity, in both, small intestine and caecum, after 22 weeks.
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Wine
Benefits coming from the moderate consumption of red wine (RW) have been mostly attributed to its phenolic compounds, consisting of a complex mixture of flavonoids, such as flavan-3-ols and anthocyanins, but also, of nonflavonoids, such as resveratrol, cinnamates and gallic acid. Similarly to the polyphenols derived from other food products, wine polyphenols have also been stated to display a selective modulation of gut microbiota 32 . Thus, Dolara et al. 38 reported changes in the main bacterial strains of wine polyphenol-treated F344 rats (50 mg/kg for 15 weeks) compared to the control-fed rats. The wine polyphenolic extract contained 4.4% anthocyanins, 0.8% flavonols, 2.0% phenolic acids, 1.4% catechin, 1.0% epicatechin and 28% proanthocyanidin.
Bacteroides, Lactobacillus and Bifidobacterium spp. were more predominant in faeces of polyphenol-treated rats, whereas Bacteroides, Clostridium and Propionibacterium spp. prevailed in control-fed rats' faeces. The authors underlined the potentiality of wine polyphenols to simulate the favourable effects of fibres and prebiotics on the colonic bacterial content. 38 An in vitro batch culture fermentation model carried out with human faecal microbiota aimed to observe the bacteria-polyphenol interactions implicated in the colonic metabolism of RW polyphenols. 39 In this study, the slight inhibition observed in Clostridium histolyticum were in concordance with the conclusions drawn with monomeric flavan-3-ols and cocoa flavan-3-ols in previously mentioned batch culture models. 19, 30 Nevertheless, the lack of positive effects found on the growth of Lactobacillus/Enterococcus spp. in this experiment, 39 was ascribed to the lower concentrations of flavan-3-ol compounds provided (20.94 mg/L) compared to the 219 mg/L used by Tzounis et al. 19, 30 In an intervention study, Queipo-Ortuño et al. 40 investigated the changes produced in the faecal microbiota of ten healthy human volunteers after the consecutive intake of RW, dealcoholized red wine (DRW), and gin.
After a washout period of two weeks, the small number of participants enrolled to the study was crossed from one treatment to the other, which might help the authors having a greater statistical power. However, the fact that there were three treatments with the absence of washout periods between them was a limitation that required discussion.
Based on data from the monitorization of urine resveratrol metabolites after each treatment, the authors were able to conclude that there was not any carryover from treatment to treatment, thus, this issue was discarded as a confounding factor. 40 Regarding gut microbiota, differences were observed depending on the type of beverage consumed. Briefly, four mayor bacteria phyla (Proteobacteria, Fusobacteria, Firmicutes and Bacteroidetes) were markedly increased after RW intake, and relevant increases in Bifidobacterium and Prevotella species were detected. In contrast, no changes were found in Actinobacteria phyla and marked decreases were identified in the Clostridium genera and Clostridium histolyticum group with RW. Nevertheless, these effects were less pronounced or even disappeared with DRW. Interestingly, the induction of gut microbiota remodelling due to the intake of small amounts of ethanol with polyphenols, was linked to reductions in blood pressure, triglycerides, total cholesterol and CRP. 40 Table 1 summarizes the main results from studies analyzing polyphenol-rich beverages and gut microbiota composition.
Soy products
Soy products, coming from soybeans (members of Leguminosae), are rich in phytoestrogens, principally in the form of isoflavones. At this stage, a study that evaluated the impact of diverse soymilk formula consumption on the intestinal ecosystem of human overweight and obese men found a better Firmicutes to
Bacteroidetes ratio in the soymilk-fed groups. 41 Soymilk intake in newborns was found to slightly enlarge the number of Bifidobacterium species in the infants. 42 Nevertheless, neither analyzed the isoflavone content of the soymilk or soy formula milk used; therefore, the slight modifications observed could not be attributed to specific components of the milk. The use of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) to prove the influence of a soygerm powder in the fermentative capacity of bacteria from inoculated faecal samples has been focus of interest. 43 Moreover, in vivo studies with probiotic soy products have been also performed and differences on fecal microbiota have been reported. Bedani et al., 44 analyzed bacterial genus composition in rats faeces that were administered the Enterococcus faecium CRL 183 probiotic microorganism with a soy product, either as a pure cell suspension or as a fermented product. Data were compared to microbial changes observed in rats treated with the unfermented soy product. In this case, no reductions in pathogenic genus such as, Clostridium spp., Bacteroides spp. or enterobacteria were concluded for the animals treated with the fermented soy products and only an enhancement in the growth of Lactobacillus spp. was obtained for the animals administered the E. faecium suspension. 44 Cavallini et al., 45 in contrast, performed another experiment, in which a probiotic soy product was administered to white rabbits and posterior analyses of microbiota were performed in vitro. In this case, the difference in bacterial populations obtained between fermented and unfermented products were more significant regarding with PPE, which was accompanied by a marked increase in the production of short chain fatty acids. In contrast, no significant effect was observed in gut bacteria grown in media supplemented with punicalagins (0.2% w/v). 27 Larrosa et al. 46 reported for the first time the prebiotic effect of PPE using a dextran sodium sulphate-induced colitis rat model. The intake of 250 mg PPE/kg/day (equivalent to 2.5 g PPE in a 70 kg-person) for 3 weeks increased Bifidobacterium, Lactobacillus and Clostridium counts preventing the colonization and invasion of tissues by enterobacteria including E. coli.
In addition, the same results were obtained when the rats were fed synthetic urolithin A (2.2 mg/kg/day; equivalent to 154 mg in a 70 kg person), which demonstrated that the main gut microbiota-derived metabolite from pomegranate ellagitannins, urolithin A, also showed prebiotic effect. 46 Neyrinck et al. 47 emphasized the enhancement of the caecal pool of bifidobacteria in mice fed a high-fat diet supplemented with the PPE (rich in polyphenols, 30%). In addition, a down-regulation of the expression of inflammatory markers (IL-1β, IL-6, COX-2) in colon and visceral adipose tissue was demonstrated for the latter group. Therefore, a direct relationship between PPE consumption and health improvement through gut microbiota modulation was hypothesized by the authors.
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Apples
Apple contains a high amount of pectin, a polysaccharide fiber that has been described to influence intestinal microbiota, but is also rich in phenolic compounds with high antioxidant capacity. Licht et al. 48 argued that changes in the microbiota of apple-fed rats should be ascribed to pectin. 48 Rats that received an extraction juice from apples (total polyphenols, 829 mg/L) for 4 weeks, instead of drinking water, showed significantly more Lactobacillus and Bifidobacterium in fresh faeces. 49 The same research group also observed an increase in Bacteroidaceae species in Wistar rats' offered juice colloids isolated from apple pomace extraction juices, which presented higher contents of dietary fiber and polyphenols. 50 Moreover, as previously reported, in a study where apple pectin (5 g/100 g) and polyphenol-rich apple concentrate (10 g/100 g) was given to rats, even if microbiota analyses were not conducted, a more effective biological effect was demonstrated when both components were administered in combination, implying the important role of the phenolic compounds.
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Grapes
Grape fruits are rich in polyphenols, mainly, anthocyanins, flavonols, favan-3-ols,
hydroxybenzoates and phenolic acids. An in vitro study was conducted in order to analyze the potential of two grape seed flavan-3-ol fractions in the growth and metabolism of Bifidobacterium spp., Lactobacillus/Enterococcus spp., Clostridium histolyticum group, Bacteroides spp. and members of the domain Bacteria. 52 The analyzed grape seed extracts (GSE) differed in their composition of monomers and oligomers. Monomeric-rich fraction of GSE (GSE-M) contained 70% monomers and 28% procyanidins, whereas oligomeric-rich fraction of GSE (GSE-O) was composed of 21% monomers and 78% procyanidins. In spite of these composition differences, both extracts produced comparable effects on microbiota composition. For instance, a selective inhibitory action on Clostridium histolyticum was described for both fractions within 5-10 h of fermentation period, this being statistically significant only for GSE-O at 10h of fermentation. During these first hours, an increase in Lactobacillus/Enterococcus group was also found in both cases, although statistical significance was only achieved for the fractions with the highest flavan-3-ol monomers fraction. 52 The water: acetic acid extraction. 54 In another study, three commercial GSE, which differed in their flavan-3-ol profiles, were assayed to test their effect on the growth of several Lactobacillus and bifidobacteria strains. 55 Briefly, a general inhibition of bacterial growth was observed as the most common response. Although dependent on the polyphenol extract composition and the bacterial strain tested, this growth repression increased with the procyanidin content of the extract and was observed not only to be species specific, but also strain specific. Interestingly, even if Lactobacillus and Bifidobacteria were likewise sensitive to the phenolic concentration and to the content of procyanidins, specific strains such as L. casei and L. plantarum were able to reach maximal growth with the three extracts. 55 Viveros et al. 56 analyzed and compared cecal and ileal digesta from broiler chicks treated with GSE and grape pomace concentrate (GPC) by plate count and Terminal restriction fragment lenght polymorphism (T-RFLP) method. The impact of both extracts on bacterial ecosystem of both regions was noticed to differ. Besides, T-RFLP approach made possible to confirm that major changes in treated groups were given in uncultured and unidentified species. 56 Moreover, the combination of grape polyphenols with dietary fiber has been demonstrated to improve the desired prebiotic effect. This is the case of grape antioxidant dietary fiber (GADF), a natural product derived from red grapes that was demonstrated to boost Lactobacili growth, in rats (50g/kg) but also in vitro, whereby GADF was able to significantly increase the growth of L. acidophilus and L. reuteri. 57 Staphylococcus and Salmonella were the most sensitive, and the strongest inhibitory action was observed with cloudberry and raspberry, being this outcome largely attributed to their ellagitannin content (191 and 146 mg/g, respectively). Importantly, the lower pH produced on the media was hypothesized as a possible explanation for the antimicrobial action, as it seems that low pH values promote the growth of probiotic bacteria, while pathogenic bacteria present high variability in their tolerance to acids. 60 Wild blueberry (Vaccinum augustifolium) is characterized by its high content in anthocyanidins, whose prebiotic activity has been documented in vitro and in vivo.
Thus, soluble extracts of two New Zealand blueberry cultivars promoted the growth of L. rhamnosus and B. breve in vitro and, more importantly, both extracts were demonstrated to effectively induce the growth of Lactobacilli and Bifidobacteria in the caecum of rats orally gavaged with these extracts (4 mL/kg/day) for 6 days. 61 Caecal contents of rats treated with supplements, whose major component was the blackcurrant extract powder, were also estimated using the Fluorescent in situ hybridization (FISH)
technology. Rats administered the blackurrant aqueous extract presented a significant increase in bifidobacterial numbers and a significant decrease in bacteroides and clostridial numbers. 62 In an intervention study with 15 healthy male individuals who underwent a dietary intervention where a wild blueberry drink was given before or after a placebo drink, a significant increase in Bifidobacterium spp. and Lactobacillus acidophilus group was also detected.
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Conclusions
This review has outlined some of the current work carried out facing the impact of polyphenols or polyphenol-rich dietary sources on gut microbial ecosystem evidencing an interaction between gut microbes and these compounds. When comparing results obtained from in vitro studies with data from in vivo experiments, no direct extrapolations could be made without a special mention to diverse factors acting up on this process.
Type of in vitro experiments
In this regard, the in vitro experiments discussed in this work have been performed by different approaches, such as in vitro traditional culture techniques or cultivation, in vitro faecal batch culture fermentation systems and Simulator of the Human Intestinal Microbial Ecosystem (SHIME).
Bacteria inoculation with individual polyphenols
The simplest experiments where diverse bacteria species were inoculated with pure polyphenols have been useful to confirm that either flavonoids or non-flavonoids could produce an antimicrobial activity against pathogenic bacteria, 16 but also a growth promoting effect for some beneficial commensal bacteria. 26 Nevertheless, the biological relevance of these types of outcomes is uncertain, as polyphenols bioavailability is very low and they undergo an extensive modification within the organism. 64 In this sense, special care should be taken as in vitro studies do not consider that some polyphenols are directly absorbed in the small intestine, while others reach the colon being degraded by microbiota to produce metabolites which, in some cases, could be more active than the original compounds. 65 There are many review articles that elegantly explain polyphenols biotransformation in the gut, which is not the core of this work.
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Anyway, a basic concept such as the fact that the chemical structure of polyphenols largely influences their absorption and metabolism should be taken into account. In this sense, glycosides that reach the colon will be hydrolysed into aglycones by microflora and will subsequently suffer other structural modifications, such as methylation, sulfation and glucuronidation processes. 64 This is relevant to understand some data from in vitro experiments, as for instance the work reported by Duda-Chodak et al. 16 , who concluded that aglycones (naringenin, quercetin and hesperetin) were powerful antibacterial compounds compared to their glycosides (naringin and rutin). Therefore, when trying to draw any conclusive statement about the biological effect of a certain polyphenol, the author´s should be aware of the process of compounds` bioconversion, in order to avoid the use of erroneous polyphenols in their experiments. 64 On the other hand, in these studies a limited number of bacterial species were inoculated, ignoring the bacterial complexity found in the intestine. metabolisers. This is the case of daidzein, a soy isoflavone, whose metabolism gives equol (whose biological properties might be beyond its precursors`) when equolforming bacteria are present in the intestine. 67 Knowledge about the conversion of the mentioned compound has allowed discerning a great variability between individuals regarding their ability to produce its metabolite, attributed to differences in their gut microbiota composition. 68 This sort of information might be useful for personalized nutritional recommendations in the future. Anyway, there are other factors apart from the hosts` baseline gut microbiota composition, such as genetics and the metabolic state of the host that should be considered in order to be able to clarify the exact mechanisms contributing to the health benefits and to distinguish the direct correlation between bacterial strains and the metabolic products resulted from their interaction with polyphenols.
Batch culture fermentation system
In this regard, the use of batch culture fermentation systems has been also reported in this work. 27 This approach, characterized to exhibit similar conditions to the human colonic region, aims to assess the effect of polyphenols 27 or polyphenol-rich extracts 27, , , 30 39 61 on the growth of faecal bacteria population using human faecal slurries. Even if these systems are static models that aim to give information about colonic degradation of polyphenols and allow scientists to fix strict conditions regarding oxygen, temperature and pH of the medium, an important point to bear in mind is that faecal samples used might not entail the same characteristics of daily faecal production.
Moreover, one of the main limitations when trying to address the gut microbial polyphenol metabolism in these types of assays is the interindividual variability. Faecal samples obtained from different individuals will exhibit distinct bacterial population for numerous reasons (i.e. diet, exercise, water, absorption/hydratation state, minor infections, stress and so on), thus they could present a variable metabolic capacity 69 giving rise to different conclusions.
Simulator of the Human Intestinal Microbial Ecosystem (SHIME)
Another undeniable factor affecting results is the repercussion of the experiments´ duration. In contrast to the aforementioned in vitro static systems, continuous multistaged culture systems that simulate the human microbial community in the large intestine have been developed. 70 Studies carried out in SHIME models 32, 43 have allowed scientists to assess in vitro the implication of a two-week continuous treatment period with black tea, wine extract or a soygerm powder in colonic microbiota composition. As a matter of fact, even if this system is considered to better mimic the real polyphenolgut microbial interaction happening in the organism, it should be underlined that this approach takes for granted that the extracts reach intact to the colonic region, which is far from the reality. 15 Moreover, owing to the high inter-relationship between host factors and the complex intestinal bacteria community, in vitro studies should be supported with further research in vivo and with human intervention trials to be able to elucidate the mechanisms underlying this interaction.
In vivo studies and human intervention studies
This review summarizes data from 16 studies conducted in animal models compared to 8 human intervention studies. It is widely known that preliminary evidences should be warranted in animal models before human intervention trials. In fact, they contribute to better understand the mechanisms and biological effects that could be likely to happen in human biology. Furthermore, a good design in human studies is indispensable in order to make as feasible as possible the conclusions drawn. In many cases it can be difficult to count on volunteers collaboration who meet the criteria and are ready to begin a relatively long-term study (4 to 10 weeks), so that the number of participants enrolled might be quite poor (8 subjects to 22 subjects). This might lead the researchers to sketch crossover studies 30 in which participants are randomly subjected to a sequence of two or more treatments, and allow removing participants' variation, as well as being more efficient than trials performed in parallel with the same number of subjects.
However, their principal disadvantage is that the effects of one treatment might "carryover" and modify the response to the following treatments. In fact, some trials cited in the present work 40 have skipped the wash out periods between treatments that might be key in order to favour the continuation of the study by the participants.
Quantification techniques
The final technique used for the bacteria identification and quantification is of great relevance. It is widely known that 60-80% of bacterial species have been reported to be non-cultivable by culture-dependent methods. Thus, these approaches failed to identify a large fraction of gut microbial diversity. Interestingly, at present, the advances gained in molecular techniques have made possible to overcome limitations of culture dependent methods 71 being able to give a more representative view of all bacterial community in the gut. Nevertheless, these techniques should be complementary, and ideally an inter-disciplinary approach comprising several "omics" approaches without the exclusion of culture-dependent techniques should be conducted. An example of this combination could be found in an experiment performed by Kemperman et al. 32 , where data obtained from different microbiological analyses (cultivation, qPCR, PCR-DGGE and 16S rRNA pyrosequencing) were compared and the previously mentioned limitations of traditional culture techniques became visible. The culture-dependent technique used in this experiment estimated a lower bacterial number and was not able to detect conclusive antimicrobial effect of the extracts tested, whereas the aforementioned techniques were able to distinguish different bacterial clusters depending on the tested compounds. 32 In general, from the articles cited in this review, it could be suggested that culture-dependent techniques were mainly focused on the identification/quantification of six genus (Lactobacillus, Bifidobacterium, Escherichia, Salmonella, Staphylococcus and Bacillus) belonging to one of three major classes (Firmicutes, Proteobacteria, Actinobacteria), conduct an in-depth characterization of bacterial populations at species levels. However, briefly, it could be said that even a lot of progress has been made in the last years in the area of gut microbiota, still some challenges regarding parameters such as sampling, the sequencing depth and setting the limits of the regions to be analyzed remain to be agreed so that experiments could be completely reproducible. The advances in sequencing technology will permit to detect all the bacterial species and strains, at a level of detail much more precise than the previously used techniques.
Final remarks
From a health perspective, the intake of phenolic compounds, either as pure compounds or as part of food constituents, could be an effective approach to modulate gut microbiota, enhancing the growth of specific beneficial bacteria strains, while competitively excluding specific pathogenic bacteria. However, further research is 
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